IMNM logo

Immunome, Inc. (IMNM) Cash From Operations

Annual CFO:

-$110.79M-$103.23M(-1363.98%)
December 31, 2024

Summary

  • As of today, IMNM annual cash from operations is -$110.79 million, with the most recent change of -$103.23 million (-1363.98%) on December 31, 2024.
  • During the last 3 years, IMNM annual cash from operations has fallen by -$92.57 million (-507.89%).
  • IMNM annual cash from operations is now -1396.00% below its all-time high of -$7.41 million, reached on December 31, 2018.

Performance

IMNM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

Quarterly CFO:

-$49.40M+$3.65M(+6.89%)
June 30, 2025

Summary

  • As of today, IMNM quarterly cash from operations is -$49.40 million, with the most recent change of +$3.65 million (+6.89%) on June 30, 2025.
  • Over the past year, IMNM quarterly cash from operations has dropped by -$26.00 million (-111.14%).
  • IMNM quarterly cash from operations is now -304.36% below its all-time high of $24.17 million, reached on March 31, 2023.

Performance

IMNM Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

TTM CFO:

-$178.68M-$26.00M(-17.03%)
June 30, 2025

Summary

  • As of today, IMNM TTM cash from operations is -$178.68 million, with the most recent change of -$26.00 million (-17.03%) on June 30, 2025.
  • Over the past year, IMNM TTM cash from operations has dropped by -$118.04 million (-194.66%).
  • IMNM TTM cash from operations is now -4303.32% below its all-time high of $4.25 million, reached on June 30, 2023.

Performance

IMNM TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IMNM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-1364.0%-111.1%-194.7%
3Y3 Years-507.9%-512.9%-603.9%
5Y5 Years-1054.1%--

IMNM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1364.0%at low-304.4%+6.9%-4303.3%at low
5Y5-Year-1364.0%at low-304.4%+6.9%-4303.3%at low
All-TimeAll-Time-1396.0%at low-304.4%+6.9%-4303.3%at low

IMNM Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$49.40M(+6.9%)
-$178.68M(-17.0%)
Mar 2025
-
-$53.05M(-26.1%)
-$152.68M(-37.8%)
Dec 2024
-$110.79M(-1364.0%)
-$42.06M(-23.1%)
-$110.79M(-28.5%)
Sep 2024
-
-$34.17M(-46.0%)
-$86.19M(-42.1%)
Jun 2024
-
-$23.40M(-109.5%)
-$60.64M(-41.3%)
Mar 2024
-
-$11.17M(+36.0%)
-$42.91M(-467.0%)
Dec 2023
-$7.57M(+73.6%)
-$17.46M(-102.7%)
-$7.57M(-335.9%)
Sep 2023
-
-$8.61M(-52.0%)
$3.21M(-24.5%)
Jun 2023
-
-$5.67M(-123.4%)
$4.25M(+128.7%)
Mar 2023
-
$24.17M(+461.7%)
$1.86M(+106.5%)
Dec 2022
-$28.69M
-$6.68M(+11.7%)
-$28.69M(+0.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$7.57M(+6.1%)
-$28.81M(-13.5%)
Jun 2022
-
-$8.06M(-26.4%)
-$25.39M(-20.5%)
Mar 2022
-
-$6.38M(+6.3%)
-$21.07M(-15.6%)
Dec 2021
-$18.23M(-50.2%)
-$6.80M(-64.2%)
-$18.23M(-4.2%)
Sep 2021
-
-$4.14M(-10.8%)
-$17.48M(-31.1%)
Jun 2021
-
-$3.74M(-5.8%)
-$13.34M(-39.0%)
Mar 2021
-
-$3.54M(+41.7%)
-$9.60M(-18.1%)
Dec 2020
-$12.13M(-26.4%)
-$6.06M(-193.7%)
-$8.13M(-293.7%)
Mar 2020
-
-$2.06M
-$2.06M
Dec 2019
-$9.60M(-29.6%)
-
-
Dec 2018
-$7.41M
-
-

FAQ

  • What is Immunome, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Immunome, Inc.?
  • What is Immunome, Inc. annual cash from operations year-on-year change?
  • What is Immunome, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Immunome, Inc.?
  • What is Immunome, Inc. quarterly cash from operations year-on-year change?
  • What is Immunome, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Immunome, Inc.?
  • What is Immunome, Inc. TTM cash from operations year-on-year change?

What is Immunome, Inc. annual cash from operations?

The current annual cash from operations of IMNM is -$110.79M

What is the all-time high annual cash from operations for Immunome, Inc.?

Immunome, Inc. all-time high annual cash from operations is -$7.41M

What is Immunome, Inc. annual cash from operations year-on-year change?

Over the past year, IMNM annual cash from operations has changed by -$103.23M (-1363.98%)

What is Immunome, Inc. quarterly cash from operations?

The current quarterly cash from operations of IMNM is -$49.40M

What is the all-time high quarterly cash from operations for Immunome, Inc.?

Immunome, Inc. all-time high quarterly cash from operations is $24.17M

What is Immunome, Inc. quarterly cash from operations year-on-year change?

Over the past year, IMNM quarterly cash from operations has changed by -$26.00M (-111.14%)

What is Immunome, Inc. TTM cash from operations?

The current TTM cash from operations of IMNM is -$178.68M

What is the all-time high TTM cash from operations for Immunome, Inc.?

Immunome, Inc. all-time high TTM cash from operations is $4.25M

What is Immunome, Inc. TTM cash from operations year-on-year change?

Over the past year, IMNM TTM cash from operations has changed by -$118.04M (-194.66%)
On this page